These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21276754)

  • 1. Management of uncommon chemotherapy-induced emergencies.
    Morgan C; Tillett T; Braybrooke J; Ajithkumar T
    Lancet Oncol; 2011 Aug; 12(8):806-14. PubMed ID: 21276754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicologic emergencies in the intensive care unit: management using reversal agents and antidotes.
    Patel SR
    Crit Care Nurs Q; 2013; 36(4):335-44. PubMed ID: 24002424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Hematologic and Oncologic Emergencies.
    Stephanos K; Dubbs SB
    Emerg Med Clin North Am; 2021 Aug; 39(3):555-571. PubMed ID: 34215402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapy emergencies.
    Albanell J; Baselga J
    Semin Oncol; 2000 Jun; 27(3):347-61. PubMed ID: 10864222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines.
    Roselló S; Blasco I; García Fabregat L; Cervantes A; Jordan K;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv100-iv118. PubMed ID: 28881914
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy-induced emergencies.
    Schneider SM; Distelhorst CW
    Semin Oncol; 1989 Dec; 16(6):572-8. PubMed ID: 2688116
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid-Associated Side Effects: A Symptom Management Update on Multiple Myeloma Treatment
.
    King T; Faiman B
    Clin J Oncol Nurs; 2017 Apr; 21(2):240-249. PubMed ID: 28315528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real.
    Argyriou AA; Assimakopoulos K; Iconomou G; Giannakopoulou F; Kalofonos HP
    J Pain Symptom Manage; 2011 Jan; 41(1):126-39. PubMed ID: 20832978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pets might reduce side-effects related to chemotherapy in patients with cancer.
    Aral H; Altundag K
    J BUON; 2021; 26(3):1173. PubMed ID: 34268992
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.
    Fernandez-Montero JV; Eugenia E; Barreiro P; Labarga P; Soriano V
    Expert Opin Drug Saf; 2013 Sep; 12(5):697-707. PubMed ID: 23730950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patient treated with chemotherapy. Alarm signs requiring immediate intervention].
    Mende S
    MMW Fortschr Med; 2001 Mar; 143(12):26-9. PubMed ID: 11302082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The onset of adverse events induced by chemotherapy for patients with malignancy].
    Tsukuda M
    Nihon Rinsho; 2003 Jun; 61(6):917-22. PubMed ID: 12806936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.
    Brahmer JR; Lacchetti C; Thompson JA
    J Oncol Pract; 2018 Apr; 14(4):247-249. PubMed ID: 29517954
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatologic emergencies.
    Chacon AH
    Cutis; 2015 Feb; 95(2):E28-31. PubMed ID: 25750975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of acute contrast media reactions: assessing preparedness of a tertiary care veterans affairs medical center.
    Favinger J; Bastawrous S; Bhargava P
    J Am Coll Radiol; 2013 Nov; 10(11):872-4. PubMed ID: 23433785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current guidelines for prevention and management of chemotherapy extravasation].
    Bahyrycz J; Pityński K; Ludwin A; Ludwin I; Gawlik M
    Przegl Lek; 2012; 69(12):1283-6. PubMed ID: 23750440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.
    Cury-Martins J; Eris APM; Abdalla CMZ; Silva GB; Moura VPT; Sanches JA
    An Bras Dermatol; 2020; 95(2):221-237. PubMed ID: 32165025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute reactions to chemotherapy agents.
    de Lemos ML
    J Oncol Pharm Pract; 2006 Sep; 12(3):127-9. PubMed ID: 17022867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress of the mechanism for chemotherapeutic drugs induced neurotoxicity and its clinical treatment research].
    Zhang JZ; Zheng WH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):286-8. PubMed ID: 22574611
    [No Abstract]   [Full Text] [Related]  

  • 20. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
    Sauerland C; Engelking C; Wickham R; Corbi D
    Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.